BioTech Mag Search: Therapeutics
With Phase 2 Data in Hand, Ovid Eyes Multiple Pivotal Trials for Epilepsy Drug
Ovid Therapeutics and Takeda Pharmaceutical joined forces three years ago to develop a small molecule into a potential epilepsy drug. That research is starting to pay off as...
1 hour ago - Xconomy - 2 articles
Alnylam Reports Positive Topline Results from ILLUMINATE-B Phase 3 Study of Lumasiran for the Treatment of Primary Hyperoxaluria Type 1 in Children Under the Age of Six
CAMBRIDGE, Mass.--Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, announced today positive topline results from the ILLUMINATE-B pediatric Phase 3 study...
6 hours ago - San Diego Biotechnology - 2 articles
Associate Scientist, Cancer Biology & Translational Research - Turning Point Therapeutics - San Diego, CA
Analyze and document experimental data in notebooks in a timely and accurate manner per company policies. We are applying a highly refined design methodology...From Turning...
12 hours ago - San Diego Biotechnology - 3 articles
Cardiff Oncology Prices Public Offering
SAN DIEGO, Sept. 29, 2020 /PRNewswire/ - Cardiff Oncology, Inc. , a clinical-stage oncology therapeutics company developing drugs to treat cancers with the greatest medical...
12 hours ago - San Diego Biotechnology
Vividion Therapeutics, Inc.: Associate Scientist / Senior Associate Scientist, Biology
Vividion Therapeutics, Inc.: Vividion is a privately held biotechnology company based in San Diego that is leveraging an innovative and proprietary chemical proteomics platform...
15 hours ago - San Diego Biotechnology - 3 articles
Fate Therapeutics, Inc.: Scientist / Associate Scientist, cGMP Cell Line Development
Fate Therapeutics, Inc.: Fate's Cellular Reprogramming and Engineering Department is seeking a skilled and highly motivated cGMP manufacturing scientist / associate...
19 hours ago - San Diego Biotechnology - 4 articles
Senior Scientist - Cancer Therapeutics - Novartis / GNF - Novartis - San Diego, CA
The work will involve the design and execution of novel target identification and validation efforts that leverage GNF's unique automation and functional...From Novartis - Tue...
19 hours ago - San Diego Biotechnology - 4 articles
Temporary Research Assistant/ Research Associate, Bioanalytical - Arcturus Therapeutics Inc - San Diego, CA
Perform initial analysis of experimental data and interpret immediate outcomes. Ability to keep organized data and records. Performs other duties as assigned.From Arcturus...
22 hours ago - San Diego Biotechnology - 4 articles
Temporary Research Assistant/ Research Associate, Bioanalytical - Arcturus Therapeutics Inc - San Diego, CA
Perform initial analysis of experimental data and interpret immediate outcomes. Ability to keep organized data and records. Performs other duties as assigned.From Arcturus...
23 hours ago - San Diego Biotechnology - 3 articles
Dewpoint Therapeutics to put 'pedal to the metal' with $77M round
Dewpoint Therapeutics to put 'pedal to the metal' with $77M round amysokolow2020 Mon, 09/28/2020 - 19:57
1 day ago - Fierce Biotech
Free Registration
The headlines of BioTech Mag
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
With Phase 2 Data in Hand, Ovid Eyes Multiple Pivotal Trials for Epilepsy Drug
Ovid Therapeutics and Takeda Pharmaceutical joined forces three years ago to develop a small molecule into a potential epilepsy drug. That research is starting to pay off as...
Pfizer Pumps $200M Into CStone for Rights to PD-L1 Cancer Drug in China
CStone Pharmaceuticals has touted its experimental drug sugemalimab as potentially the best in its class of cancer immunotherapies. Pfizer is placing a bet on that promise by...
New Research Provides Clues on Optimizing Cell Defenses When Viruses Attack
UC San Diego scientists are providing new clues on how cells defend themselves from attack from viruses. The new study advance's science's understanding of interferons...
Kawasaki Disease is not a Homogenous Disease nor are its Triggers
Researchers at UC San Diego report that while Kawasaki disease occurs in clusters, the traits, and thus the triggers of the inflammatory disease vary among clusters. ...
Orphazyme Stock Sale Reaps $83M as Neimann-Pick Drug Review Begins
Orphazyme has fresh cash from the sale of shares in the US and Europe, which will support its lead rare disease drug through regulatory review and, if approved, a launch. But...
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
Praxis Precision Medicines kept mostly quiet about its research on central nervous system disorder drugs until May, when it emerged from stealth and revealed $100 million in...
Scientists Research New Ways to Tackle Brain Cancer
Glioblastoma is an aggressive brain tumor that is difficult to treat. Its cells are skilled migrators. Their knack for infiltration makes it nearly impossible for any treatment...
Shhh! These Tests Will Enable a Quieter Search for Dark Matter
Brianna Mount, assistant professor of physics at Black Hills State University, at work in the Black Hills State University Underground Campus at Sanford Lab, where components...
Spinal Cord Stimulation Reduces Pain and Motor Symptoms in Parkinson's...
A team of researchers in the United States and Japan reports that spinal cord stimulation measurably decreased pain and reduced motor symptoms of Parkinson's disease, both as a...
Genetic Testing Cost Effective for Newly Diagnosed GIST
UC San Diego School of Medicine researchers reported that genetic testing is cost-effective and beneficial for newly diagnosed patients with metastatic gastrointestinal stromal...